INMUNE BIO INC. Shareholders' Equity
INMUNE BIO INC. (INMB) had Shareholders' Equity of $20.36 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $20.36M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $19.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $23.52M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $25.38M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $20.36M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $19.62M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $23.52M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $25.38M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $28.87M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $29.67M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $32.10M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $38.67M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $36.28M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | $28.22M 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $37.34M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $43.93M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $50.65M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $55.30M 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $60.10M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $63.71M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $69.93M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $75.64M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $80.22M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $88.25M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $43.23M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $63.56M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $38.75M 10-K · filed 2023-03-02 | $38.75M 10-K · filed 2021-03-04 |
| 2020-09-30 | $41.21M 10-Q · filed 2021-11-03 | $41.21M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $21.68M 10-Q · filed 2021-11-03 | $21.68M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $22.41M 10-Q · filed 2021-11-03 | $22.41M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $23.61M 10-K · filed 2022-03-03 | $23.61M 10-K · filed 2020-03-11 |
| 2019-09-30 | $24.71M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $26.84M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $22.86M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $16.54M 10-K · filed 2021-03-04 | |
| 2018-09-30 | $17.47M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $18.03M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $18.63M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $18.10M 10-K · filed 2020-03-11 | |
| 2016-12-31 | -$149.20K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |